To include your compound in the COVID-19 Resource Center, submit it here.

Qnexa phentermine/topiramate endocrine data

Researchers at Columbia University Medical Center reported data from a retrospective analysis of medical claims and pharmacy prescription data from the Wolters Kluwer Pharma Solutions Source Lx Patient Longitudinal Database showing that infants exposed to topiramate in utero did not have a significantly increased risk of developing oral clefts or major congenital malformations. The study analyzed 778 mother-infant

Read the full 585 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers